NervGen Pharma Corp is among the group of undervalued stocks on the TSX Venture Exchange. This means the consensus value for each stock on this list is above its current price.
This report is generated monthly. It provides the close price and target price for these companies along with the number of analysts covering the stock. Also included is the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year. Stocks in this category are held primarily for capital appreciation.
There may be a number of reasons why a company would be on this list. Companies with a large analyst following with a difference in price versus target are worth exploring in more detail.
Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # Estimates |
---|
SGML | Sigma Lithium Corp | 2024 | 44.2 | 64.5 | CAD | 4 |
ARTG | Artemis Gold Inc | 2024 | 6.29 | 11.0833 | CAD | 9 |
PMET | Patriot Battery Metals Inc | 2025 | 9.72 | 17.25 | CAD | 6 |
NFG | New Found Gold Corp | 2024 | 4.67 | 9.7625 | CAD | 4 |
SGD | Snowline Gold Corp | 2024 | 5.1 | 10.25 | CAD | 4 |
SLI | Standard Lithium Corp | 2024 | 2.73 | 8.25 | CAD | 2 |
MTA | Metalla Royalty & Streaming Ltd | 2024 | 4.07 | 9 | CAD | 2 |
ODV | Osisko Development Corp | 2024 | 4.12 | 8.22 | CAD | 5 |
LTH | Lithium Ionic Corp | 2024 | 1.74 | 5.35 | CAD | 5 |
EMX | EMX Royalty Corp | 2024 | 2.14 | 5.75 | USD | 1 |
LIFT | Li-FT Power Ltd | 2024 | 5.4 | 11.75 | CAD | 2 |
NOU | Nouveau Monde Graphite Inc | 2024 | 3.48 | 8.5 | CAD | 1 |
CRE | Critical Elements Lithium Corp | 2024 | 0.92 | 4.01 | CAD | 5 |
ETL | E3 Lithium Ltd | 2024 | 2.07 | 5.7 | CAD | 1 |
HITI | High Tide Inc | 2024 | 2.06 | 6.0625 | CAD | 4 |
NGEN | NervGen Pharma Corp | 2024 | 1.82 | 5 | CAD | 1 |
GPV | GreenPower Motor Company Inc | 2025 | 4.05 | 9.4849 | CAD | 1 |
GIP | Green Impact Partners Inc | 2024 | 4.64 | 14 | CAD | 5 |
HAM | Highwood Asset Management Ltd | 2024 | 4.82 | 9 | CAD | 2 |
KUT | Redishred Capital Corp | 2024 | 3 | 6.3333 | CAD | 3 |
FCLI | Full Circle Lithium Corp | 2024 | 0.5 | 4 | CAD | 1 |
CNX | Callinex Mines Inc | 2024 | 1.78 | 5.85 | CAD | 2 |
GAME | GameSquare Holdings Inc | 2024 | 2.32 | 7 | USD | 1 |
FCA-U | Firm Capital Apartment REIT | 2024 | 2.25 | 6.0744 | CAD | 2 |
KWE | KWESST Micro Systems Inc | 2024 | 1.15 | 5 | USD | 1 |
All data provided as of December 21, 2023.
More about NervGen Pharma Corp
NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer's disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.
NervGen Pharma Corp is listed under NGEN on the TSX Venture Exchange.
Artificial intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.